Elsevier

American Journal of Otolaryngology

Volume 16, Issue 2, March–April 1995, Pages 103-108
American Journal of Otolaryngology

Original contribution
Prognostic significance of keratinization in nasopharyngeal carcinoma

https://doi.org/10.1016/0196-0709(95)90040-3Get rights and content

Abstract

Introduction: Keratinization may be a vulnerable aid in predicting response to therapy for nasopharyngeal carcinoma.

Methods: The presence or absence of keratin in biopsy specimens was correlated with tumor behavior, locoregional control, patterns of failure, and survival of patients irradiated for nasopharyngeal carcinoma.

Results: Patients with keratinizing squamous-cell cancers (World Health Organization [WHO] type 1) had a higher incidence (76%) of locally advanced tumors than those with nonkeratinizing (WHO type 2) and undifferentiated (WHO type 3) cancers (55%). The former group of patients had a lower incidence (29%) of lymph node metastases than the later group (70%). Primary tumor was controlled in 62% and neck nodes were controlled in 82% of all patients. Primary tumor control rates were 29% in patients with keratinizing squamous-cell cancers and 79% in those with nonkeratinizing and undifferentiated cancers (P = .001). Nodal control rates were 76% for keratinizing squamous-cell cancer and 85% for nonkeratinizing and undifferentiated cancers (P = .001). The incidence of distant metastases was 6% in patients with keratinizing squamous-cell cancer and 33% in those with nonkeratinizing and undifferentiated cancers (P = .001). Patients with keratinizing squamous-cell cancers, even though they had a lower incidence of lymphatic and distant metastases, had a poorer survival rate because of a higher incidence of deaths from uncontrolled primary tumors and nodal metastases. The 5-year survival rates were 35% for all patients, 6% for those with keratinizing squamous-cell cancers, and 51% for nonkeratinizing and undifferentiated cancers respectively (P = .001).

Conclusion: Higher doses of external beam radiotherapy with or without brachytherapy boost may be needed to improve local control and survival of patients with keratinizing squamous-cell carcinoma of the nasopharynx, whereas an effective systemic therapy is needed for nonkeratinizing and undifferentiated cancers, which tend to metastasize.

References (23)

  • C.A. Perez et al.

    Cancer of the nasopharynx. Factors influencing prognosis

    Cancer

    (1969)
  • Cited by (126)

    • Survival effect of pretreatment FDG-PET–CT on nasopharyngeal cancer

      2023, Journal of the Formosan Medical Association
      Citation Excerpt :

      Although NPC is rare in most parts of the world, it is endemic in Hong Kong, Singapore, and Taiwan, where undifferentiated, nonkeratinizing squamous cell carcinoma is the predominant histology.4–6 The World Health Organization (WHO) classifies NPC into three histopathologic types.7 The endemic form of NPC is commonly the undifferentiated, nonkeratinizing subtype (WHO type III); this is strongly associated with Epstein–Barr virus and has a more favorable prognosis than other types.8

    • Squamous Cell Carcinoma of the Upper Aerodigestive System

      2020, Gnepp's Diagnostic Surgical Pathology of the Head and Neck, Third Edition
    • Pathology classification of nasopharyngeal carcinoma

      2020, An Evidence-Based Approach to the Management of Nasopharyngeal Cancer: From Basic Science to Clinical Presentation and Treatment
    • Laboratory investigation for nasopharyngeal carcinoma diagnosis

      2020, An Evidence-Based Approach to the Management of Nasopharyngeal Cancer: From Basic Science to Clinical Presentation and Treatment
    View all citing articles on Scopus
    View full text